|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.84 SEK | +8.39% |
|
+12.75% | -82.82% |
Redeye updates its estimates following Sozap’s Q1 report. The Q1 came in roughly in line in with our expectations in terms of sales while profitability was lower than expected due to higher UA investments.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source
| 1st Jan change | Capi. | |
|---|---|---|
| -82.82% | 9L | |
| +19.54% | 6.52TCr | |
| +45.72% | 459.41Cr | |
| -31.95% | 34Cr | |
| +34.75% | 34Cr | |
| -32.61% | 32Cr | |
| -37.36% | 22Cr | |
| -39.23% | 22Cr | |
| +1.79% | 15Cr | |
| +14.62% | 14Cr |
SOZAP AB 
